Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer.
作者： Guangcheng Guo , Xin Duan , Dongwei Dou , Xinxing Wang , Yujie Zhang
DOI: 10.1038/S41419-021-03684-X
关键词:
摘要: … , we found that 13 circRNAs were downregulated and 19 circRNAs were upregulated in TNBC … Among these abnormally expressed circRNAs, the expression levels of four circRNAs that …
nature.com
sci-hub.st 参考文章(36)
Samit Chatterjee, Babak Behnam Azad, Sridhar Nimmagadda, The intricate role of CXCR4 in cancer. Advances in Cancer Research. ,vol. 124, pp. 31- 82 ,(2014) , 10.1016/B978-0-12-411638-2.00002-1
Agnieszka Rybak-Wolf, Christin Stottmeister, Petar Glažar, Marvin Jens, Natalia Pino, Sebastian Giusti, Mor Hanan, Mikaela Behm, Osnat Bartok, Reut Ashwal-Fluss, Margareta Herzog, Luisa Schreyer, Panagiotis Papavasileiou, Andranik Ivanov, Marie Öhman, Damian Refojo, Sebastian Kadener, Nikolaus Rajewsky, Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed Molecular Cell. ,vol. 58, pp. 870- 885 ,(2015) , 10.1016/J.MOLCEL.2015.03.027
Kathryn E. Luker, Gary D. Luker, Functions of CXCL12 and CXCR4 in breast cancer. Cancer Letters. ,vol. 238, pp. 30- 41 ,(2006) , 10.1016/J.CANLET.2005.06.021
Eugene H. Huang, Balraj Singh, Massimo Cristofanilli, Juri Gelovani, Caimiao Wei, Laura Vincent, Kendra R. Cook, Anthony Lucci, A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer1 Journal of Surgical Research. ,vol. 155, pp. 231- 236 ,(2009) , 10.1016/J.JSS.2008.06.044
M. De Laurentiis, D. Cianniello, R. Caputo, B Stanzione, G. Arpino, S. Cinieri, V. Lorusso, S. De Placido, Treatment of triple negative breast cancer (TNBC): current options and future perspectives Cancer Treatment Reviews. ,vol. 36, ,(2010) , 10.1016/S0305-7372(10)70025-6
Akihiko Muto, Satoshi Tashiro, Osamu Nakajima, Hideto Hoshino, Satoru Takahashi, Eiichirou Sakoda, Dai Ikebe, Masayuki Yamamoto, Kazuhiko Igarashi, The transcriptional programme of antibody class switching involves the repressor Bach2 Nature. ,vol. 429, pp. 566- 571 ,(2004) , 10.1038/NATURE02596
Hagen Kennecke, Rinat Yerushalmi, Ryan Woods, Maggie Chon U. Cheang, David Voduc, Caroline H. Speers, Torsten O. Nielsen, Karen Gelmon, Metastatic Behavior of Breast Cancer Subtypes Journal of Clinical Oncology. ,vol. 28, pp. 3271- 3277 ,(2010) , 10.1200/JCO.2009.25.9820
Jingyu Xiang, Michelle A. Hurchla, Francesca Fontana, Xinming Su, Sarah R. Amend, Alison K. Esser, Garry J. Douglas, Chidananda Mudalagiriyappa, Kathryn E. Luker, Timothy Pluard, Foluso O. Ademuyiwa, Barbara Romagnoli, Gérald Tuffin, Eric Chevalier, Gary D. Luker, Michael Bauer, Johann Zimmermann, Rebecca L. Aft, Klaus Dembowsky, Katherine N. Weilbaecher, CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer Molecular Cancer Therapeutics. ,vol. 14, pp. 2473- 2485 ,(2015) , 10.1158/1535-7163.MCT-15-0252
Reuben J. Shaw, Lewis C. Cantley, Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. ,vol. 441, pp. 424- 430 ,(2006) , 10.1038/NATURE04869
H.-W. Chen, C.-W. Du, X.-L. Wei, U.-S. Khoo, G.-J. Zhang, Cytoplasmic CXCR4 high-expression exhibits distinct poor clinicopathological characteristics and predicts poor prognosis in triple-negative breast cancer. Current Molecular Medicine. ,vol. 13, pp. 410- 416 ,(2013) , 10.2174/156652413805076803